Edesa Biotech Reports Fiscal Year 2024 Results
Provided By GlobeNewswire
Last update: Dec 13, 2024
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the fiscal year ended September 30, 2024 and provided an update on its business.
Read more at globenewswire.comNASDAQ:EDSA (2/20/2025, 1:17:28 PM)
2.4817
-0.06 (-2.3%)
Find more stocks in the Stock Screener
EDSA Latest News and Analysis
2 days ago - ChartmillWondering what's happening in today's pre-market session?Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
